| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Intensive care medicine 39 (2), 165-228, 2013 | 18720* | 2013 |
| Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis RC Bone, RA Balk, FB Cerra, RP Dellinger, AM Fein, WA Knaus, ... Chest 101 (6), 1644-1655, 1992 | 12572* | 1992 |
| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Intensive care medicine 39 (2), 165-228, 2013 | 11266 | 2013 |
| The third international consensus definitions for sepsis and septic shock (Sepsis-3) M Singer, CS Deutschman, CW Seymour, M Shankar-Hari, D Annane, ... Jama 315 (8), 801-810, 2016 | 10719 | 2016 |
| Sccm/Esicm/Accp/Ats/Sis MM Levy Crit Care Med 31, 1250-1256, 2003 | 9531* | 2003 |
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure JL Vincent, R Moreno, J Takala, S Willatts, A De Mendonça, H Bruining, ... Intensive care medicine 22 (7), 707-710, 1996 | 8518 | 1996 |
| Efficacy and safety of recombinant human activated protein C for severe sepsis GR Bernard, JL Vincent, PF Laterre, SP LaRosa, JF Dhainaut, ... New England journal of medicine 344 (10), 699-709, 2001 | 6914 | 2001 |
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock RP Dellinger, JM Carlet, H Masur, H Gerlach, T Calandra, J Cohen, ... Intensive care medicine 30 (4), 536-555, 2004 | 5698 | 2004 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43 (3), 304-377, 2017 | 5421 | 2017 |
| The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study JL Vincent, DJ Bihari, PM Suter, HA Bruining, J White, ... Jama 274 (8), 639-644, 1995 | 3588 | 1995 |
| International study of the prevalence and outcomes of infection in intensive care units JL Vincent, J Rello, J Marshall, E Silva, A Anzueto, CD Martin, R Moreno, ... Jama 302 (21), 2323-2329, 2009 | 3209 | 2009 |
| Sepsis in European intensive care units: results of the SOAP study JL Vincent, Y Sakr, CL Sprung, VM Ranieri, K Reinhart, H Gerlach, ... Critical care medicine 34 (2), 344-353, 2006 | 3049 | 2006 |
| Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study JL Vincent, A De Mendonça, F Cantraine, R Moreno, J Takala, PM Suter, ... Critical care medicine 26 (11), 1793-1800, 1998 | 2993 | 1998 |
| Serial evaluation of the SOFA score to predict outcome in critically ill patients FL Ferreira, DP Bota, A Bross, C Mélot, JL Vincent Jama 286 (14), 1754-1758, 2001 | 2321 | 2001 |
| Anemia and blood transfusion in critically ill patients JL Vincent, JF Baron, K Reinhart, L Gattinoni, L Thijs, A Webb, ... Jama 288 (12), 1499-1507, 2002 | 1842 | 2002 |
| Comparison of dopamine and norepinephrine in the treatment of shock D De Backer, P Biston, J Devriendt, C Madl, D Chochrad, C Aldecoa, ... New England Journal of Medicine 362 (9), 779-789, 2010 | 1586 | 2010 |
| Microvascular blood flow is altered in patients with sepsis D De Backer, J Creteur, JC Preiser, MJ Dubois, JL Vincent American journal of respiratory and critical care medicine 166 (1), 98-104, 2002 | 1451 | 2002 |
| Sepsis biomarkers: a review C Pierrakos, JL Vincent Critical care 14 (1), 1-18, 2010 | 1391 | 2010 |
| Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock Y Sakr, MJ Dubois, D De Backer, J Creteur, JL Vincent Critical care medicine 32 (9), 1825-1831, 2004 | 1278 | 2004 |
| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1194 | 1994 |
